Biomea Fusion
BMEA· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -68.0% in FY2025
Michael J.M. Hitchcock, Ph.D. is the CEO of Biomea Fusion and was paid $2.6M in FY2025 (Dec).
Pay$100 in the stock at the end of FY24 → $32
Executives4
See all- 1Michael J.M. Hitchcock, Ph.D.Interim Chief Executive Officer and Principal Executive OfficerFY2025
- 2Rainer (Ramses) ErdtmannChief Operating Officer, President, Principal Financial Officer and Principal Accounting OfficerFY2025
- 3Thomas ButlerFormer Chief Executive Officer and Former Chairman of the BoardFY2025
- 4Juan Pablo Frias, M.D.Former Chief Medical OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBiomea Fusion paid its 4 named executives $6.0M in total in FY2025 (Dec). CEO Michael J.M. Hitchcock, Ph.D. was paid $2.6M of that.
| Name | |||
|---|---|---|---|
| Michael J.M. Hitchcock, Ph.D.Interim Chief Executive Officer and Principal Executive Officer | Not disclosed | Not disclosed | |
| Rainer (Ramses) ErdtmannChief Operating Officer, President, Principal Financial Officer and Principal Accounting Officer | |||
| Thomas ButlerFormer Chief Executive Officer and Former Chairman of the Board | |||
| Juan Pablo Frias, M.D.Former Chief Medical Officer | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Biomea Fusion. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board2
See all- Bihua ChenDirector · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive
- Sumita Ray, J.D.Director · 2 yr on the boardIndependentAudit, Nominating and Corporate Governance (Chair)—Paid as an executive
The board of the latest proxy (FY2023).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 27, 2026 | FY2025 |
| Annual report | 10-K | Mar 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 28, 2025 | FY2024 |
| Annual report | 10-K | Mar 31, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 26, 2024 | FY2023 |
| Annual report | 10-K | Mar 28, 2024 | FY2023 |
